Blood pressure in diabetic nephropathy - Current controversies

Journal of Internal Medicine

Volumn 249, Issue 3, 2001, Pages 215-223

  Ritz, E ^a   Rychlik I ^a   Schomig M ^a   Wagner, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ACE inhibitors; Blood pressure; Calcium channel blockers; Diabetes; Hyperglycemia; Renin angiotensin system; Tissue renin system

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN; RENIN;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; PATIENT MONITORING; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; URINARY EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS;

EID: 0035023238     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00791.x     Document Type: Review

References (76)

1. Über hypertonie und zuckerkrankheit
2. Early agressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
3. Combined high blood pressure and glucose in type 2 diabetes: Double jeopardy
4. Insulin resistance, hyperinsulinemia, and blood pressure: Role of age and obesity
5. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy
6. Genetic susceptibility and the role of hypertension in diabetic nephropathy
7. Predisposition to hypertension and susceptibility to renal disease in insulindependent diabetes mellitus
8. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy
9. Enhanced collagen synthesis in cultured skin fibroblasts from insulindependent diabetic patients with nephropathy
10. Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease
11. Protein activation in IDDM patients with diabetic nephropathy
12. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension
13. Association of a human G protein β3 subunit variant with hypertension
14. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients
15. Familial clustering of cardiovascular disease in patients with insulin dependent diabetes and nephropathy
16. The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in type I diabetes mellitus
17. Nephropathy of type II diabetes: Evidence for hereditary factors?
18. Familial predisposition to renal disease in two generation of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus
19. Renal findings in patients with short-term type 2 diabetes
20. 3 subunit 825 T-allele in dialysed patients with type 2 diabetes
21. Prevention of diabetic renal disease with special reference to microalbuminuria
22. The sixth report of the Joint National Committee on prevention detection evaluation and treatment of high blood pressure
23. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease
24. Pathogenesis, prevention, and treatment of diabetic nephropathy
25. Blood pressure, retinopathy and urinary albumin excretion in IDDM
26. 24-H blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients
27. 24-H ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients
28. Patterns of renal injury in NIDDM patients with microalbuminuria
29. How heterogenous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria
30. Long-term stabilising effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
31. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes
32. Intensified antihypertensive therapie is assosiated with improved survival in type I diabetic patients with nephropathy
33. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats
34. Diabetes - Renal function - What are the special problems?
35. The paradox of the low renin state in diabetic nephropathy
36. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus
37. Effect of glucose on the expression of the renin angiotensinogen gene in opossum kidney cells
38. Renal renin-angiotensin system in diabetes: Functional immunohistochemical and molecular biological correlations
39. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat
40. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats. Effect of sodium and salt restriction
41. Angiotensin II receptor type II gene expression in human glomerulonephritis and diabetes mellitus
42. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells
43. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule
44. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria
45. The beneficial effect of angiotensinconverting enzyme inhibition with captopril on diabetric nephropathy in normotensive IDDM patients with microalbuminuria
46. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
47. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
48. Effect of the angiotensinconverting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
49. Effect of different antihypertensive drugs on human diabetic proteinuria
50. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
51. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
52. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin-dependent diabetes and hypertension
53. Outcome Result of the Fosinopril versus Amlodipine Cardiovasculoar Events Randomized Trial (FACET) in patients with hypertension and NIDDM
54. Final outcome results of the multicenter isradipin diuretic atherosclerosis study (MIDAS). A randomised controlled trial
55. Treatment of hypertensive patients with diabetes
56. Calcium channel blockers in diabetic nephropathy - Is there life after the ABCD trial?
57. Effects of calcium-channel blockade in older patients with diabetes and systlic hypertension. Systolic hypertension in Europe trial investigator
58. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
59. Randomised trial of effects of calcium antagonists compared with diuretics and betablockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
60. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease
61. Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury
62. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
63. Audit of antihypertensive treatment in patients with renal failure
64. Blood pressure control, proteinuria, and the progression of renal disease
65. Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
66. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function
67. Dosing angiotensin II blockers - Beyond blood pressure
68. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation
69. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects
70. Progression of diabetic nephropathy - Is diurnal blood pressure rythm as important as absolute blood pressure level?
71. How far should blood pressure be lowered?
72. Clinical epidemiology of cardiovascular disease in chronic renal disease
73. Ischemia causes rapidly progressive nephropathy in the diabetic rat
74. Renal disease and hypertension in non-insulin-dependent diabetes mellitus
75. Diabetic nephropathy in Typ II diabetes